NICE recommends greater use of thrombolytics in acute myocardial infarctionBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7372.1057/b (Published 09 November 2002) Cite this as: BMJ 2002;325:1057
- Susan Mayor
More patients with acute myocardial infarction should be treated with thrombolytics, given intravenously in hospital or by bolus injection in pre-hospital settings, the National Institute for Clinical Excellence (NICE) recommended last week.
The NICE guidance says that only an estimated 50 000 of the 240 000 patients suffering an acute myocardial infarction each year in England and Wales currently receive thrombolysis, even though it is the established, standard treatment.
The appraisal committee, chaired by David Barnett, professor of clinical pharmacology at the University of Leicester, noted: “Evidence suggests that thrombolysis continues to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial